Study to Compare Ferric Carboxymaltose With Placebo in Patients With Acute Heart Failure and Iron Deficiency

NCT02937454 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1132

Enrollment

INDUSTRY

Sponsor class

Conditions

Iron Deficiency
Heart Failure

Interventions

DRUG: ferric carboxymaltose
OTHER: Normal saline 0.9%

Sponsor

Vifor (International) Inc.

Collaborators

[object Object]
[object Object]